(Q36594224)

15 August 2017

1 reference

title

Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology (English)

1 reference

15 August 2017

1 reference

Philip Mease

1

1 reference

15 August 2017

publication date

1 October 2006

1 reference

Current Rheumatology Reports

15 August 2017

published in

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

348-354

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-006-0064-9

15 August 2017

exact match

0 references

cites work

Psoriatic arthritis imaging: a review of scoring methods

1 reference

12 December 2020

Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy

1 reference

12 December 2020

Magnetic resonance imaging in spondyloarthropathies

1 reference

12 December 2020

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial

1 reference

12 December 2020

A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

1 reference

12 December 2020

The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991

1 reference

12 December 2020

Interleukin-15: a new cytokine target for the treatment of inflammatory diseases

1 reference

12 December 2020

Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept

1 reference

12 December 2020

Outcome measures in psoriatic arthritis

1 reference

12 December 2020

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

1 reference

12 December 2020

Psoriatic arthritis and imaging

1 reference

12 December 2020

Psoriatic arthritis assessment tools in clinical trials

1 reference

12 December 2020

Psoriatic arthritis treatment: biological response modifiers

1 reference

12 December 2020

Mortality studies in psoriatic arthritis. Results from a single outpatient clinic. I. Causes and risk of death

1 reference

12 December 2020

A novel targeted T-cell modulator, efalizumab, for plaque psoriasis

1 reference

12 December 2020

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Classification and diagnostic criteria for psoriatic arthritis

1 reference

12 December 2020

Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis

1 reference

12 December 2020

1 reference

12 December 2020

Psoriasis pathophysiology: current concepts of pathogenesis

1 reference

12 December 2020

Assessment of patients with psoriatic arthritis: a review of currently available measures

1 reference

12 December 2020

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

1 reference

12 December 2020

The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis

1 reference

12 December 2020

1 reference

12 December 2020

Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis

1 reference

12 December 2020

Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis

1 reference

12 December 2020

Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.

1 reference

12 December 2020

Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

1 reference

12 December 2020

Immunopathology of psoriasis and psoriatic arthritis

1 reference

12 December 2020

The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody

1 reference

12 December 2020

Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression

1 reference

12 December 2020

Psoriasis treatment: traditional therapy

1 reference

12 December 2020

Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis

1 reference

12 December 2020

Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors

1 reference

12 December 2020

Psoriasis treatment: current and emerging directed therapies

1 reference

12 December 2020

Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis

1 reference

12 December 2020

A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis

1 reference

12 December 2020

Subclinical joint involvement in psoriasis: magnetic resonance imaging and X-ray findings.

1 reference

12 December 2020

Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.

1 reference

12 December 2020

Diagnosis and treatment of psoriatic arthritis

1 reference

12 December 2020

Classification criteria for psoriatic arthritis: development of new criteria from a large international study

1 reference

12 December 2020

Epidemiology of psoriatic arthritis in the population of the United States.

1 reference

12 December 2020

Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.

1 reference

12 December 2020

10.1007/S11926-006-0064-9

Identifiers

DOI

1 reference

15 August 2017

1 reference